arrow
B

Ben Kang

Kyungpook National University
H指数:26
被引数:2,618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upadacitinib treatment in pediatric Crohn’s disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN

乌帕替尼治疗儿童克罗恩病:欧洲儿科胃肠病与营养学会(ESPGHAN)儿科炎症性肠病波尔托组国际多中心回顾性队列研究的52周结果

2026-09-210
PRE
Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study

中重度活动性溃疡性结肠炎儿童中戈利木单抗的疗效、安全性和药代动力学:PURSUIT 2研究的结果

2026-01-010
PRE
Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study

抗肿瘤坏死因子治疗反应预测模型在儿童克罗恩病中的验证:一项系统评价和前瞻性队列研究

2025-10-010
PRE
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial

全食物饮食可缓解儿童和年轻人的轻度至中度克罗恩病,并且比完全肠内营养更耐受: 一项随机对照试验

2025-06-170
OAAI
Proactive Drug Monitoring Versus Clinically Based Dosing for Endoscopic Healing in Pediatric Crohn’s Disease Receiving Infliximab

主动药物监测与基于临床的给药方案在应用英夫利昔单抗治疗儿童克罗恩病内镜愈合中的比较

2025-05-140
OAAI
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study

乌帕替尼用于诱导儿童克罗恩病缓解:一项国际多中心回顾性研究

2025-02-081
OAAI
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN
2024-05-236
OAAI
Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease
2024-02-221
OAAI
Characteristics of Pediatric Ulcerative Colitis at Diagnosis in Korea: Results From a Multicenter, Registry-Based, Inception Cohort Study

韩国儿童溃疡性结肠炎诊断时的特征: 一项多中心、基于注册登记的初始队列研究的结果

2024-01-010
OAAI
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN

溃疡性直肠炎儿科患者的临床特征和自然史: ESPGHAN儿科IBD Porto小组的多中心研究

2023-07-014
PRE